Literature DB >> 11741181

Role of Akt in growth and survival of PANC-1 pancreatic cancer cells.

Zan Yao1, Yoshinori Okabayashi, Yoshihiro Yutsudo, Tadahiro Kitamura, Wataru Ogawa, Masato Kasuga.   

Abstract

INTRODUCTION: Akt is involved in different cellular processes such as cell growth, cell differentiation, and anti-apoptosis. AIMS: To investigate the role of Akt in cell growth and survival in PANC-1 pancreatic cancer cells. METHODOLOGY AND
RESULTS: Insulin-like growth factor (IGF)-I induced Akt activation in a dose-dependent manner and stimulated anchorage-dependent and anchorage-independent cell growth of PANC-1 cells. In PANC-1 cells infected with adenovirus vectors carrying kinase-deficient Akt, anchorage-dependent and anchorage-independent cell growth was significantly reduced in the presence or absence of IGF-I compared with cells infected with adenovirus vectors carrying wild-type Akt, although IGF-I significantly stimulated cell growth in both transfected cell lines. Conversely, in PANC-1 cells infected with adenovirus vectors carrying kinase-deficient Akt, typical DNA laddering was undetectable in DNA fragmentation assay, and DNA 3;-OH reactivity was not detected in TUNEL assay. We then examined the role of phosphatidylinositol 3-kinase (PI3-K), an upstream mediator of Akt, on cell survival. In PANC-1 cells infected with adenovirus vector carrying a deletion mutant of the 85-kDa regulatory subunit of PI3-K and in cells treated with PI3-K inhibitor wortmannin, typical DNA laddering was evident in DNA fragmentation assay. In TUNEL assay, nuclear condensation and DNA 3;-OH reactivity was observed in approximately 30% of these cells.
CONCLUSION: The present results indicate that Akt is implicated in cell growth, but not in survival in PANC-1 cells. These results suggest that there may be an alternative survival signal cascade from PI3-K in PANC-1 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11741181     DOI: 10.1097/00006676-200201000-00006

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  16 in total

Review 1.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  Nanoparticle formulation of ormeloxifene for pancreatic cancer.

Authors:  Sheema Khan; Neeraj Chauhan; Murali M Yallapu; Mara C Ebeling; Swathi Balakrishna; Robert T Ellis; Paul A Thompson; Pavan Balabathula; Stephen W Behrman; Nadeem Zafar; Man M Singh; Fathi T Halaweish; Meena Jaggi; Subhash C Chauhan
Journal:  Biomaterials       Date:  2015-03-26       Impact factor: 12.479

3.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

4.  High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.

Authors:  Siong-Seng Liau; Flavio Rocha; Evan Matros; Mark Redston; Edward Whang
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

5.  Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.

Authors:  Mitsuhiko Osaki; Satoru Kase; Keiko Adachi; Ami Takeda; Kiyoshi Hashimoto; Hisao Ito
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-07       Impact factor: 4.553

6.  Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.

Authors:  Sanjit K Roy; Rakesh K Srivastava; Sharmila Shankar
Journal:  J Mol Signal       Date:  2010-07-19

Review 7.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

8.  BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells.

Authors:  Hong-Quan Duong; Jae Seok Hwang; Hee Jeong Kim; Yeon-Sun Seong; Insoo Bae
Journal:  Int J Oncol       Date:  2012-10-17       Impact factor: 5.650

9.  AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2.

Authors:  B N Fahy; M Schlieman; S Virudachalam; R J Bold
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

Authors:  M G Schlieman; B N Fahy; R Ramsamooj; L Beckett; R J Bold
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.